At EMUC25 in Prague last month, editorial board members of the UROONCO Educational Platform recorded a series of in‑depth interviews with leading experts, offering fresh perspectives on key debates and emerging evidence that was presented. These conversations provide valuable insights into clinical decision‑making, imaging, biomarkers and evolving treatment strategies across kidney cancer, bladder cancer and prostate cancer. You can listen to the interviews below:
Kidney cancer
Single agent TKI in selected mRCC patients: Assoc. Prof. Carlotta Palumbo (IT) speaks with Dr. Pasquale Rescigno (GB) about his EMUC25 debate presentation supporting the role of single agent tyrosine kinase inhibitors in carefully selected metastatic RCC patients. 🎧 Listen here
RCC with venous thrombosis: Dr. Maria Carmen Mir (US) interviews Dr. Lorenzo Bianchi (IT) on optimal imaging strategies for surgical planning and imaging‑guided approaches in RCC with venous thrombosis. 🎧 Listen here
—
Bladder Cancer
ctDNA in muscle‑invasive bladder cancer: Dr. Laura Mertens (NL) and Dr. Elisabeth Grobet-Jeandin, MD (CH) discuss with Prof. Lars Dyrskjøt (DE) the potential of ctDNA in MIBC, concluding with rapid‑fire questions on future applications. 🎧 Listen here
Managing high‑risk NMIBC: Dr. Elisabeth Grobet-Jeandin, MD (CH) and Dr. Laura Mertens (NL) interview Dr. Laura Bukavina MD MPH MSc (US) on strategies for managing high‑risk non‑muscle invasive bladder cancer. 🎧 Listen here
—
Prostate Cancer
Local therapy in metastatic prostate cancer: Dr. Pawel Rajwa (PL) talks with Prof. Thomas Zilli (CH) about the role of local therapy in metastatic prostate cancer. 🎧 Listen here
